Mannkind (MNKD) Invested Capital (2010 - 2026)
Mannkind (MNKD) reported Invested Capital of -$48.8 million for Q1 2026, down 0.56% year-over-year from -$49.1 million in Q1 2025, and down 19.89% on a QoQ basis from -$40.7 million in Q4 2025.
Mannkind (MNKD) has 17 years of Invested Capital data on file, last reported at -$48.8 million in Q1 2026.
- Quarterly Invested Capital fell 0.56% year-over-year to -$48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$48.8 million (down 0.56% YoY) and the FY2025 annual result came in at -$40.7 million, up 40.81% from the prior year.
- Invested Capital retreated to -$48.8 million in Q1 2026 per MNKD's latest filing, from -$40.7 million in the prior quarter.
- Across five years, Invested Capital topped out at -$34.3 million in Q3 2025 and bottomed at -$215.9 million in Q2 2024.
- The 5-year median for Invested Capital is -$133.7 million (2022), against an average of -$116.3 million.
- The widest annual swing landed in 2024, when Invested Capital slumped 38.04%; it then soared 82.87% in 2025.
- Tracing MNKD's Invested Capital over 5 years: stood at -$146.4 million in 2022, then increased by 2.98% to -$142.1 million in 2023, then jumped by 51.6% to -$68.8 million in 2024, then soared by 40.81% to -$40.7 million in 2025, then retreated by 19.89% to -$48.8 million in 2026.
- Per Business Quant, the three latest MNKD Invested Capital figures stand at -$48.8 million (Q1 2026), -$40.7 million (Q4 2025), and -$34.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | -48.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.79 Mn |
| Dec 31, 2025 | -40.69 Mn |
| Sep 30, 2025 | -34.25 Mn |
| Jun 30, 2025 | -44.84 Mn |
| Mar 31, 2025 | -48.52 Mn |
| Dec 31, 2024 | -68.75 Mn |
| Sep 30, 2024 | -199.93 Mn |
| Jun 30, 2024 | -215.88 Mn |
| Mar 31, 2024 | -125.87 Mn |
| Dec 31, 2023 | -142.07 Mn |
| Sep 30, 2023 | -147.68 Mn |
| Jun 30, 2023 | -156.39 Mn |
| Mar 31, 2023 | -151.40 Mn |
| Dec 31, 2022 | -146.44 Mn |
| Sep 30, 2022 | -133.68 Mn |
| Jun 30, 2022 | -143.16 Mn |
| Mar 31, 2022 | -129.16 Mn |
| Dec 31, 2021 | -108.85 Mn |
| Sep 30, 2021 | -184.69 Mn |
| Jun 30, 2021 | -178.68 Mn |
| Mar 31, 2021 | -168.95 Mn |
| Dec 31, 2020 | -176.36 Mn |
| Sep 30, 2020 | -186.42 Mn |
| Jun 30, 2020 | -179.71 Mn |
| Mar 31, 2020 | -198.05 Mn |
| Dec 31, 2019 | -190.53 Mn |
| Sep 30, 2019 | -184.71 Mn |
| Jun 30, 2019 | -96.80 Mn |
| Mar 31, 2019 | -86.30 Mn |
| Dec 31, 2018 | -103.58 Mn |
| Sep 30, 2018 | -100.74 Mn |
| Jun 30, 2018 | -77.42 Mn |
| Mar 31, 2018 | -83.01 Mn |
| Dec 31, 2017 | -160.33 Mn |
| Sep 30, 2017 | -193.07 Mn |
| Jun 30, 2017 | -163.76 Mn |
| Mar 31, 2017 | -126.93 Mn |
| Dec 31, 2016 | -112.25 Mn |
| Sep 30, 2016 | -167.80 Mn |
| Jun 30, 2016 | -291.13 Mn |
| Mar 31, 2016 | -298.45 Mn |
| Dec 31, 2015 | -275.75 Mn |
| Sep 30, 2015 | 60.83 Mn |
| Jun 30, 2015 | 129.43 Mn |
| Mar 31, 2015 | 135.47 Mn |
| Dec 31, 2014 | -775,000.00 |
| Sep 30, 2014 | -31.48 Mn |
| Jun 30, 2014 | -8.63 Mn |
| Mar 31, 2014 | 137.54 Mn |
| Dec 31, 2013 | 69.29 Mn |
| Sep 30, 2013 | -167.72 Mn |
| Jun 30, 2013 | 7.64 Mn |
| Mar 31, 2013 | -146.81 Mn |
| Dec 31, 2012 | 4.32 Mn |
| Sep 30, 2012 | -276.25 Mn |
| Jun 30, 2012 | -244.38 Mn |
| Mar 31, 2012 | -277.39 Mn |
| Dec 31, 2011 | -313.65 Mn |
| Sep 30, 2011 | -280.81 Mn |
| Jun 30, 2011 | -245.38 Mn |
| Dec 31, 2010 | -185.53 Mn |